JYOTHYLAB
Jyothy Labs share price & financials
- Price
- ₹202.28
- Market cap
- ₹7.3k Cr
- Sector
- Fast Moving Consumer Goods
- Calls analysed
- 7
Jyothy Labs Q1 FY27
What went well
- Revenue (excluding Pril and FA) grew by 8.1% in value terms and 5.3% in volume terms year-on-year, demonstrating underlying business momentum.
- Fabric Care segment maintained strong momentum, delivering over 14% value growth and 10% volume growth during the quarter.
- The newly launched bioenzyme-based Exo Liquid has made encouraging progress, despite being at an early stage of scale-up and channel expansion.
What to watch
- Gross Margin stood at 38.5%, down by 950 basis points year-on-year, primarily impacted by abnormally high input cost inflation and lower realizations.
- EBITDA Margin stood at 8.4%, down about 820 basis points year-on-year, flowing through the gross margin pressure.
What Jyothy Labs does
Jyothy Labs is a homegrown Indian FMCG company, founded in 1983, operating primarily in the Home Care and Personal Care segments across fabric care, dishwashing, household insecticides and personal care. It manufactures and markets brands including Ujala, Exo, Maxo, Margo, Henko, Mr. White, Morelight, Dr. Wool and Maya through 23 manufacturing plants and a pan-India distribution network. The company holds leading or top-two market positions in several of its core categories, including fabric whiteners, dishwash bars and mosquito-repellent coils.
Segments
- Fabric Care
- Dishwashing
- Household Insecticide
- Personal Care
- Others
- Manufacturing plants
- 23
- Retail outlets with product availability (pan-India)
- 4 million+
- Direct-reach outlets
- 1.4 million+
- Channel partners
- 10,000+
- Employees
- 8,300+
- Market position - fabric whitener (Ujala Supreme)
- #1 since launch, ~4 decades ago
Guidance record · Q1 FY27
what the last two calls moved 11 tracked 0 delivered 5 missed 6 open- Operating EBITDA Margin missed said Q3 FY25 Promised: 16% to 17% for the next financial year Q1 FY27: 8.4% - Target period FY26 has passed. New guidance issued for FY27.
- Volume-Value Growth Gap on track said Q3 FY25 Promised: 2% to 3% gap over a fairly long period of time Q1 FY27: 2.8% gap (Value growth 8.1%, Volume growth 5.3% ex-Pril/FA). Within original target range.
All 11 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q4 FY25: revenue up 1.1%, net profit down 2.6% against the same quarter last year.
| Line item | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 687 | 732 | 678 | 660 | 742 +8% | 734 +0% | 704 +4% | 667 +1% |
| EBITDA | 117 | 135 | 119 | 108 | 133 +14% | 138 +2% | 116 −3% | 112 +4% |
| Net profit | 96 | 104 | 91 | 78 | 102 +6% | 105 +1% | 87 −4% | 76 −3% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −40.1% 1Y
1Y: ₹325.7 on 10 Sept 2025 → ₹195.06. High ₹325.95 (15 Sept 2025), low ₹189.12 (8 Jul 2026).
How the price took the results
close before → close after
- Q1 FY27
- −1.8%
- 12 Aug
- Q4 FY26
- +0.9%
- 4 May
- Q3 FY26
- +2.4%
- 9 Feb
- Q2 FY26
- −1.0%
- 12 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 7.0% a year over 2 years, FY23 to FY25. Operating margin widened to 17.5%.
| Year ending | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | ₹2.5k Cr | ₹2.8k Cr | ₹2.8k Cr |
| Operating profit | ₹315 Cr | ₹479 Cr | ₹499 Cr |
| Operating margin | 12.7% | 17.4% | 17.5% |
| Interest | ₹12 Cr | ₹4 Cr | ₹5 Cr |
| Depreciation | ₹50 Cr | ₹50 Cr | ₹56 Cr |
| Net profit | ₹239 Cr | ₹369 Cr | ₹370 Cr |
| Net margin | 9.6% | 13.4% | 13.0% |
| ROCE | 18.0% | 27.0% | 25.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Equity capital | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr | ₹37 Cr |
| Reserves | ₹1.2k Cr | ₹1.4k Cr | ₹1.4k Cr | ₹1.5k Cr | ₹1.8k Cr | ₹2.0k Cr |
| Borrowings | ₹285 Cr | ₹117 Cr | ₹171 Cr | ₹47 Cr | ₹51 Cr | ₹61 Cr |
| Other liabilities | ₹323 Cr | ₹410 Cr | ₹408 Cr | ₹466 Cr | ₹542 Cr | ₹580 Cr |
| Total liabilities | ₹1.8k Cr | ₹2.0k Cr | ₹2.0k Cr | ₹2.1k Cr | ₹2.4k Cr | ₹2.7k Cr |
| Fixed assets | ₹1.1k Cr | ₹1.1k Cr | ₹1.1k Cr | ₹1.1k Cr | ₹1.1k Cr | ₹1.1k Cr |
| Capital work in progress | ₹24 Cr | ₹10 Cr | ₹8 Cr | ₹15 Cr | ₹13 Cr | ₹22 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹192 Cr | ₹456 Cr |
| Other assets | ₹662 Cr | ₹799 Cr | ₹893 Cr | ₹930 Cr | ₹1.1k Cr | ₹1.1k Cr |
| Total assets | ₹1.8k Cr | ₹2.0k Cr | ₹2.0k Cr | ₹2.1k Cr | ₹2.4k Cr | ₹2.7k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +3.13 pp while DIIs trimmed −2.62 pp. The shareholder count grew 12% to 2,47,104.
- Promoters
- 62.9%
- FIIs
- 12.1%
- DIIs
- 13.4%
- Government
- 0.0%
- Public
- 11.6%
Since Jun 2025
- Public +3.13 pp
- DIIs −2.62 pp
- FIIs −0.53 pp
How it drifted, 12 quarters
Over this window the public went from 8.4% to 11.6% — +3.2 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 62.9%, FIIs 14.6%, DIIs 14.1%, Public 8.4%.Dec '23: Promoters 62.9%, FIIs 14.7%, DIIs 13.8%, Public 8.6%.Mar '24: Promoters 62.9%, FIIs 16.4%, DIIs 13.3%, Government 0.0%, Public 7.4%.Jun '24: Promoters 62.9%, FIIs 15.1%, DIIs 14.3%, Public 7.7%.Sep '24: Promoters 62.9%, FIIs 15.1%, DIIs 15.3%, Public 6.8%.Dec '24: Promoters 62.9%, FIIs 14.3%, DIIs 15.3%, Public 7.5%.Mar '25: Promoters 62.9%, FIIs 13.1%, DIIs 16.3%, Government 0.0%, Public 7.7%.Jun '25: Promoters 62.9%, FIIs 12.7%, DIIs 16.0%, Government 0.0%, Public 8.5%.Sep '25: Promoters 62.9%, FIIs 12.1%, DIIs 16.1%, Government 0.0%, Public 8.9%.Dec '25: Promoters 62.9%, FIIs 12.8%, DIIs 15.1%, Government 0.0%, Public 9.2%.Mar '26: Promoters 62.9%, FIIs 12.3%, DIIs 14.6%, Government 0.0%, Public 10.1%.Jun '26: Promoters 62.9%, FIIs 12.1%, DIIs 13.4%, Government 0.0%, Public 11.6%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Nalanda India Equity Fund Limited FPI fund +0.08 pp 5.96% held
The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Jyothy Labs above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| M. P. Ramachandran Family Trust II (Trustees being M. P. Ramachandran, M. R. Jyothy and M. R. Deepthi) | 39.12% | unchanged |
| Nalanda India Equity Fund Limited FPI fund | 5.96% | +0.08 pp |
| Sahyadri Agencies Limited | 3.95% | unchanged |
| M P Divakaran | 3.94% | unchanged |
| Canara Robeco Mutual Fund A/C Canara Robeco Large And Mid Cap Fund Mutual fund | 3.15% | −0.06 pp |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund Mutual fund | 2.91% | unchanged |
| M P Sidharthan | 2.84% | unchanged |
| M R Deepthy | 2.82% | unchanged |
| M R Jyothy | 2.82% | unchanged |
| Mirae Asset Multicap Fund Mutual fund | 1.88% | −0.52 pp |
| U B Beena | 1.88% | unchanged |
| M. P. Ramachandran Family Trust I (Trustees being M. G. Shanthakumari, M. R. Jyothy and M. R. Deepthi) | 1.75% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in JYOTHYLAB
Filings to Aug 2026
0 new, 0 added, 0 trimmed, 0 sold out — net +0.00 L shares (+0.0%).
- Held by funds
- ₹252 Cr
- 3 schemes
- Biggest holder
- Nippon India Small Cap Fund
- ₹218 Cr · 0.3% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| Nippon India Small Cap Fund Nippon India Mutual Fund | ₹218 Cr | held | Nov '19 |
| SBI Consumption Opportunities Fund SBI Mutual Fund | ₹31 Cr | held | Apr '26 |
| SBI Long Term Advantage Fund - Series VI SBI Mutual Fund | ₹4 Cr | held | Apr '26 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Aug 2026
0 added, 0 trimmed — net 0 shares (+0.0%)
- Funds are sitting on
- +5%
- vs est. average cost
- Held by funds
- ₹252 Cr
- 3 schemes · ≈ 3.4% of the company
- Biggest holder
- Nippon India Small Cap Fund
- ₹218 Cr · 0.3% of that fund
Shares held by these funds +11%
Aug '23 1.24 cr shares Jul '26
What the price assumes
AttractiveTo justify its price of ₹195, this stock must grow earnings at 13% every year for 7 years. Our analysis caps realistic growth at ~24%. At that growth it is worth ₹352 — upside of 80%.
- Growth the price implies
- 12.9% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 24.4% a year
- net profit, FY23–FY25 · EPS 24.3%
- The gap
- -0.1 pp
- 80% downside if it only repeats history
All earnings calls (7)
Read the Q1 FY27 call →Learn to analyse Jyothy Labs
Guides on how to read this kind of business and the numbers that matter.